168 related articles for article (PubMed ID: 34249685)
1. Genomic Landscape of Chinese Clear Cell Renal Cell Carcinoma Patients With Venous Tumor Thrombus Identifies Chromosome 9 and 14 Deletions and Related Immunosuppressive Microenvironment.
Niu S; Liu K; Xu Y; Peng C; Yu Y; Huang Q; Wu S; Cui B; Huang Y; Ma X; Zhang X; Wang B
Front Oncol; 2021; 11():646338. PubMed ID: 34249685
[TBL] [Abstract][Full Text] [Related]
2. The impact of histology on clinicopathologic outcomes for patients with renal cell carcinoma and venous tumor thrombus: a matched cohort analysis.
Kaushik D; Linder BJ; Thompson RH; Eisenberg MS; Lohse CM; Cheville JC; Leibovich BC; Boorjian SA
Urology; 2013 Jul; 82(1):136-41. PubMed ID: 23642851
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a prognostic model incorporating tumor thrombus grading for nonmetastatic clear cell renal cell carcinoma with tumor thrombus: A multicohort study.
Qu L; Chen H; Chen Q; Ge S; Jiang A; Yu N; Zhou Y; Kunc M; Zhou Y; Feng X; Zhai W; Wu Z; He M; Li Y; Chen R; Han B; Zeng X; Fu Y; Ji C; Fan X; Zhang G; Zhao C; Jing T; Feng C; Zhao H; Sun D; Wang L; Tai S; Zhang C; Chen S; Liu Y; Wang H; Gao J; Gu Y; Miao H; Zhao T; Yi X; Tang C; Fu D; He H; Rao Q; Zhou W; Xu N; Wang G; Liang C; Liu Z; Xia D; Zu X; Chen M; Guo H; Qin W; Wang Z; Xue W; Shi B; Wang S; Zheng J; Chen C; Zapała Ł; Ge J; Wang L
MedComm (2020); 2023 Aug; 4(4):e300. PubMed ID: 37484972
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations in renal cell carcinomas from Chinese patients revealed by whole exome sequencing.
Wang J; Xi Z; Xi J; Zhang H; Li J; Xia Y; Yi Y
Cancer Cell Int; 2018; 18():159. PubMed ID: 30349421
[TBL] [Abstract][Full Text] [Related]
5. Integrative transcriptome and proteome analyses of clear cell renal cell carcinoma develop a prognostic classifier associated with thrombus.
Shi X; Pang Q; Nian X; Jiang A; Shi H; Liu W; Gan X; Gao Y; Yang Y; Ji J; Tan X; Xiao C; Zhang W
Sci Rep; 2023 Jun; 13(1):9778. PubMed ID: 37328520
[TBL] [Abstract][Full Text] [Related]
6. The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma.
Monjaras-Avila CU; Lorenzo-Leal AC; Luque-Badillo AC; D'Costa N; Chavez-Muñoz C; Bach H
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175653
[TBL] [Abstract][Full Text] [Related]
7. Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
Kawakami F; Sircar K; Rodriguez-Canales J; Fellman BM; Urbauer DL; Tamboli P; Tannir NM; Jonasch E; Wistuba II; Wood CG; Karam JA
Cancer; 2017 Dec; 123(24):4823-4831. PubMed ID: 28832979
[TBL] [Abstract][Full Text] [Related]
8. Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma.
Zhang D; Ni Y; Wang Y; Feng J; Zhuang N; Li J; Liu L; Shen W; Zheng J; Zheng W; Qian C; Shan J; Zhou Z
J Transl Med; 2023 Jul; 21(1):489. PubMed ID: 37474942
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma.
Zhang W; Liu W; Yang Y; Xiao C; Xiao Y; Tan X; Pang Q; Wu H; Hua M; Shi X
Front Oncol; 2023; 13():1102623. PubMed ID: 37035174
[TBL] [Abstract][Full Text] [Related]
10. Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy.
Zhang C; Li Y; Qian J; Zhu Z; Huang C; He Z; Zhou L; Gong Y
Front Immunol; 2022; 13():1020729. PubMed ID: 36479115
[TBL] [Abstract][Full Text] [Related]
11. Origins and Timing of Emerging Lesions in Advanced Renal Cell Carcinoma.
Wallace A; Porten SP; Lo AA; Oreper D; Lounsbury N; Havnar C; Pechuan-Jorge X; Zill OA; Meng MV
Mol Cancer Res; 2022 Jun; 20(6):909-922. PubMed ID: 35297992
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral CXCL13
Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528
[TBL] [Abstract][Full Text] [Related]
13. Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA.
Kluzek K; Srebniak MI; Majer W; Ida A; Milecki T; Huminska K; van der Helm RM; Silesian A; Wrzesinski TM; Wojciechowicz J; Beverloo BH; Kwias Z; Bluyssen HAR; Wesoly J
Oncotarget; 2017 Apr; 8(17):28558-28574. PubMed ID: 28212566
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
[TBL] [Abstract][Full Text] [Related]
15. Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus.
Wang XM; Lu Y; Song YM; Dong J; Li RY; Wang GL; Wang X; Zhang SD; Dong ZH; Lu M; Wang SY; Ge LY; Luo GD; Ma RZ; George Rozen S; Bai F; Wu D; Ma LL
Nat Commun; 2020 Feb; 11(1):739. PubMed ID: 32029730
[TBL] [Abstract][Full Text] [Related]
16. Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma.
Lin H; Fu L; Li P; Zhu J; Xu Q; Wang Y; Mumin MA; Zhou X; Chen Y; Shu G; Yao G; Chen M; Lu J; Zhang L; Liu Y; Zhao Y; Bao J; Chen W; Luo J; Li X; Chen Z; Cao J
J Transl Med; 2023 May; 21(1):343. PubMed ID: 37221577
[TBL] [Abstract][Full Text] [Related]
17. Relevance of arm somatic copy number alterations for oncologic outcomes and tumor immune microenvironment in clear cell renal cell carcinoma.
Xiong Y; Qi Y; Bai Q; Xia Y; Liu L; Guo J
Ann Transl Med; 2019 Nov; 7(22):646. PubMed ID: 31930047
[TBL] [Abstract][Full Text] [Related]
18. Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8
Lu T; Zhang J; Lu S; Yang F; Gan L; Wu X; Song H; Liu S; Xu C; Han D; Yang B; Wen W; Qin W; Yang L
Cancer Immunol Immunother; 2023 Jun; 72(6):1739-1750. PubMed ID: 36646951
[TBL] [Abstract][Full Text] [Related]
19. A MUCINs expression signature impacts overall survival in patients with clear cell renal cell carcinoma.
Meng H; Jiang X; Huang H; Shen N; Guo C; Yu C; Yin G; Wang Y
Cancer Med; 2021 Sep; 10(17):5823-5838. PubMed ID: 34327857
[TBL] [Abstract][Full Text] [Related]
20. Comparison of PD-L1 Scores in Primary Kidney Tumors Versus Accompanying Venous Tumor Thrombi: Retrospective, Comparative, Monocentric Study in Treatment-Naive Patients.
Mazdak M; Ringlstetter R; Tabrizi PF; Akkoyun M; Wolters M; Schmitz J; Bräsen JH; Peters I; Kuczyk MA; Tezval H
Adv Ther; 2021 Jun; 38(6):3373-3388. PubMed ID: 34021481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
